A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype
Ruth S. Waterman, Suzanne L. Tomchuck, Sarah L. Henkle et al. · 2010
Read A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype by Ruth S. Waterman, Suzanne L. Tomchuck, Sarah L. Henkle et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010088.txt.
Description
The authors were Ruth Waterman, Suzanne Tomchuck, Sarah Henkle, and others. Their 2010 PLOS ONE paper proposed a new way to think about stem cell therapy. Human mesenchymal stem cells can calm or stir immune responses. Signals from Toll-like receptors, which sense danger, shift how those cells behave.
From that evidence, the team described two states, named MSC1 and MSC2. One state favors inflammation, while the other suppresses immune activity. If doctors can push cells into the right state before treatment, stem cell therapy could become far more predictable. Their proposal appeared in PLOS ONE in 2010.
Catalog record
| CREATOR | Ruth S. Waterman, Suzanne L. Tomchuck, Sarah L. Henkle et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 71 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010088